Today: 8 June 2026
McDonald’s stock rebounds as McRib lawsuit hits headlines — what could move MCD next
6 January 2026
1 min read

McDonald’s stock rebounds as McRib lawsuit hits headlines — what could move MCD next

NEW YORK, Jan 6, 2026, 15:48 EST — Regular session

McDonald’s Corp shares rose about 1% on Tuesday to $302.94, recovering ground after the company pushed back against a proposed class action tied to its McRib sandwich. The stock traded between $298.36 and $304.19 during the session, with about 2.3 million shares changing hands.

The bounce comes after McDonald’s shares fell 1.1% on Monday to $299.86, extending a six-session slide and leaving the stock about 8% below its 52-week high. Rival moves were mixed on Monday, with Starbucks closing higher while Yum Brands slipped.

In the lawsuit, plaintiffs seek to represent U.S. consumers who bought the McRib, arguing the name and rib-shaped patty mislead buyers about the meat’s quality and composition. The filing seeks damages and a court order that would force changes to marketing — a form of relief known as an injunction.

Traders are also watching U.S. data that can shift expectations for interest rates and consumer demand, both key inputs for restaurant stocks. The Labor Department’s employment report for December 2025 is due on Jan. 9, and the December 2025 consumer price index report is scheduled for Jan. 13.

The next Federal Reserve policy decision is expected at the central bank’s Jan. 27-28 meeting, putting fresh focus on how quickly borrowing costs may fall — and on whether spending momentum holds up as 2026 gets underway.

Still, the legal dispute adds a risk layer that can linger even if it does not turn into a major financial hit. If the case advances, it could bring costs and unwanted scrutiny at a time investors remain alert to any sign that price-sensitive customers are pulling back.

Next up, investors will look to McDonald’s quarterly results, expected on Feb. 9, for updates on traffic, pricing and margins — and for any read-through on how consumers are behaving early in the year.

Stock Market Today

  • 3 Stocks for Long-Term Hold Despite Market Volatility
    June 8, 2026, 10:08 AM EDT. An investor reveals three stocks they plan to hold for the next 20 years amid potential market corrections and inflation concerns. The picks include Berkshire Hathaway (BRKA, BRKB), known for its diverse holdings and low market sensitivity (beta 0.62), with stable leadership transition following Warren Buffett's 2026 retirement. Intuitive Surgical (ISRG) is highlighted for its dominance in robotic surgical systems, steady recurring revenue from service contracts, and growth through new product approvals. These selections reflect confidence in resilient business models and leadership despite short-term market uncertainty.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Merck stock hits 52-week high as vaccine policy shift and JPM conference loom
Previous Story

Merck stock hits 52-week high as vaccine policy shift and JPM conference loom

Synopsys stock climbs as CES automotive push and chip rally lift SNPS shares
Next Story

Synopsys stock climbs as CES automotive push and chip rally lift SNPS shares

Go toTop